Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
276.83
+3.83 (1.40%)
At close: Sep 11, 2026, 4:00 PM EDT
278.26
+1.43 (0.52%)
After-hours: Sep 11, 2026, 7:30 PM EDT
CRL Market Cap
CRL has a market cap or net worth of $13.28 billion as of September 11, 2026. Its market cap has increased by 76.11% in one year.
Market Cap
13.28B
Enterprise Value
16.13B
1-Year Change
76.11%
Ranking
Category
Stock Price
$276.83
ChartMarket Cap Chart
Since June 23, 2000, CRL's market cap has increased from $226.30M to $13.28B, an increase of 5,770.00%. That is a compound annual growth rate of 16.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 13.28B | 35.31% |
| Dec 31, 2025 | 9.82B | 4.00% |
| Dec 31, 2024 | 9.44B | -22.16% |
| Dec 29, 2023 | 12.13B | 9.38% |
| Dec 30, 2022 | 11.09B | -41.69% |
| Dec 31, 2021 | 19.01B | 52.98% |
| Dec 31, 2020 | 12.43B | 66.59% |
| Dec 31, 2019 | 7.46B | 37.05% |
| Dec 31, 2018 | 5.44B | 5.01% |
| Dec 29, 2017 | 5.18B | 43.75% |
| Dec 30, 2016 | 3.61B | -3.79% |
| Dec 31, 2015 | 3.75B | 25.52% |
| Dec 31, 2014 | 2.99B | 17.00% |
| Dec 31, 2013 | 2.55B | 40.28% |
| Dec 31, 2012 | 1.82B | 34.64% |
| Dec 30, 2011 | 1.35B | -34.13% |
| Dec 31, 2010 | 2.05B | -7.60% |
| Dec 31, 2009 | 2.22B | 25.20% |
| Dec 31, 2008 | 1.77B | -60.32% |
| Dec 31, 2007 | 4.47B | 54.46% |
| Dec 29, 2006 | 2.89B | -5.57% |
| Dec 30, 2005 | 3.06B | 2.77% |
| Dec 31, 2004 | 2.98B | 89.75% |
| Dec 31, 2003 | 1.57B | -9.52% |
| Dec 31, 2002 | 1.74B | 17.55% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Illumina | 31.17B |
| Quest Diagnostics | 25.94B |
| Mettler-Toledo International | 25.92B |
| Labcorp Holdings | 25.27B |
| Guardant Health | 21.12B |
| Medpace Holdings | 16.40B |
| Revvity | 13.87B |
| ICON Public Limited Company | 13.06B |